Diabetes

Chronic diabetic skin wounds are notoriously slow to heal, sometimes becoming so infected that amputations are required. A newly identified polymer could help keep that from happening, by radically boosting the healing process.

The US Food and Drug Administration (FDA) has approved the first drug that can delay the onset of type 1 diabetes. A recent trial has shown that the drug, named teplizumab, can give patients several extra disease-free years.

A study has shed light on the mystery of how high blood glucose leads to type 2 diabetes. The discovery reveals glucose metabolites can damage insulin-producing pancreatic beta cells, and disrupting this process could offer a way to treat the disease.

Stanford researchers have created a functional cure for diabetes in mice, by giving them a hybrid immune system. Treated animals were able to manage their blood glucose levels for the duration of the trial, without needing immune suppressants.

Our immune system can unfortunately go rogue and attack healthy tissues. Scientists at Johns Hopkins University have now engineered a protein that may help prevent these autoimmune diseases by boosting the number of regulatory T cells (Tregs).

Scientists studying the activity of a drug used to treat rheumatoid arthritis have discovered some surprising metabolic functions, some of which may be useful when it comes to countering diabetes and obesity.

A new review is presenting strong evidence the development of type 1 diabetes is linked to a large group of common viruses. The findings build on an old hypothesis, with vaccines currently in development targeting the most likely viral strains.

Technology that delivers insulin orally rather than regular injections would be a game-changing advance in medical science, and a team of MIT scientists has made a breakthrough in this space in the form of a drug capsule with a robotic, tunneling head.

Two studies, both yet to be peer-reviewed and published, have reached contradictory conclusions about the link between COVID and type 1 diabetes in children, affirming the lack of clarity researchers still face in determining this particular association.

Researchers from Rutgers University have conducted a close investigation of the metabolic differences between night owls and early birds, finding those who prefer staying up late may be at greater risk of type 2 diabetes and heart disease.

New research has analyzed data from nearly 20 studies encompassing one million adults and found a link between drinking tea and a reduced risk of type 2 diabetes. But it all depends on how much tea your drink.

A new animal study has shown sugar contributes to metabolic diseases by altering the microbiome. The findings reveal how certain gut bacteria protect against the harmful effects of a high-fat diet, and how sugar disrupts those protective mechanisms.